142 related articles for article (PubMed ID: 33007554)
1. N-phenyl ureidobenzenesulfonates, a novel class of promising human dihydroorotate dehydrogenase inhibitors.
Bouzriba C; Larcher L; Gagné-Boulet M; Fortin S
Bioorg Med Chem; 2020 Nov; 28(22):115739. PubMed ID: 33007554
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterisation and biological evaluation of new N-phenyl amidobenzenesulfonates and N-phenyl ureidobenzenesulfonates inducing DNA double-strand breaks. Part 3. Modulation of ring A.
Gagné-Boulet M; Bouzriba C; Godard M; Fortin S
Eur J Med Chem; 2018 Jul; 155():681-694. PubMed ID: 29936355
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel N-phenyl ureidobenzenesulfonate derivatives as potential anticancer agents. Part 2. Modulation of the ring B.
Gagné-Boulet M; Moussa H; Lacroix J; Côté MF; Masson JY; Fortin S
Eur J Med Chem; 2015 Oct; 103():563-73. PubMed ID: 26408815
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
Vyas VK; Variya B; Ghate MD
Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the DNA damage response to SFOM-0046, a new small-molecule drug inducing DNA double-strand breaks.
Pauty J; Côté MF; Rodrigue A; Velic D; Masson JY; Fortin S
Sci Rep; 2016 Mar; 6():23302. PubMed ID: 27001483
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.
Sainas S; Pippione AC; Giorgis M; Lupino E; Goyal P; Ramondetti C; Buccinnà B; Piccinini M; Braga RC; Andrade CH; Andersson M; Moritzer AC; Friemann R; Mensa S; Al-Kadaraghi S; Boschi D; Lolli ML
Eur J Med Chem; 2017 Mar; 129():287-302. PubMed ID: 28235702
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional Naphtho[2,3-
Zuo Z; Liu X; Qian X; Zeng T; Sang N; Liu H; Zhou Y; Tao L; Zhou X; Su N; Yu Y; Chen Q; Luo Y; Zhao Y
J Med Chem; 2020 Jul; 63(14):7633-7652. PubMed ID: 32496056
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase.
Boa AN; Canavan SP; Hirst PR; Ramsey C; Stead AM; McConkey GA
Bioorg Med Chem; 2005 Mar; 13(6):1945-67. PubMed ID: 15727850
[TBL] [Abstract][Full Text] [Related]
9. Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-carboxylic acids derived from phenolic aldehydes: Synthesis, cytotoxicity, lipophilicity and molecular docking studies.
Petrović MM; Roschger C; Chaudary S; Zierer A; Mladenović M; Jakovljević K; Marković V; Botta B; Joksović MD
Bioorg Chem; 2020 Dec; 105():104373. PubMed ID: 33074120
[TBL] [Abstract][Full Text] [Related]
10. Phenyl 4-(2-oxopyrrolidin-1-yl)benzenesulfonates and phenyl 4-(2-oxopyrrolidin-1-yl)benzenesulfonamides as new antimicrotubule agents targeting the colchicine-binding site.
Gagné-Boulet M; Bouzriba C; Chavez Alvarez AC; Fortin S
Eur J Med Chem; 2021 Mar; 213():113136. PubMed ID: 33472119
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel series of hDHODH inhibitors with anti-pulmonary fibrotic activities.
Lu K; Zhao Y; Wu G; Hu H; Wang M; Gong G; Jiang Y
Bioorg Chem; 2019 May; 86():44-51. PubMed ID: 30685643
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-,4,-6-, and/or 7-substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents: 3D QSAR-assisted design.
Vyas VK; Qureshi G; Oza D; Patel H; Parmar K; Patel P; Ghate MD
Bioorg Med Chem Lett; 2019 Apr; 29(7):917-922. PubMed ID: 30738663
[TBL] [Abstract][Full Text] [Related]
13. Structural Optimization and Structure-Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase.
Zeng F; Quan L; Yang G; Qi T; Zhang L; Li S; Li H; Zhu L; Xu X
Molecules; 2019 Jul; 24(15):. PubMed ID: 31370178
[TBL] [Abstract][Full Text] [Related]
14. Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.
Sainas S; Pippione AC; Lupino E; Giorgis M; Circosta P; Gaidano V; Goyal P; Bonanni D; Rolando B; Cignetti A; Ducime A; Andersson M; Järvå M; Friemann R; Piccinini M; Ramondetti C; Buccinnà B; Al-Karadaghi S; Boschi D; Saglio G; Lolli ML
J Med Chem; 2018 Jul; 61(14):6034-6055. PubMed ID: 29939742
[TBL] [Abstract][Full Text] [Related]
15. Liquid phase combinatorial synthesis of 1,2,5-trisubstituted benzimidazole derivatives as human DHODH inhibitors.
Sitwala ND; Vyas VK; Variya BC; Patel SS; Mehta CC; Rana DN; Ghate MD
Bioorg Chem; 2017 Dec; 75():118-126. PubMed ID: 28941392
[TBL] [Abstract][Full Text] [Related]
16. Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy.
Lolli ML; Sainas S; Pippione AC; Giorgis M; Boschi D; Dosio F
Recent Pat Anticancer Drug Discov; 2018; 13(1):86-105. PubMed ID: 29119937
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation, and structure-activity relationships of novel substituted N-phenyl ureidobenzenesulfonate derivatives blocking cell cycle progression in S-phase and inducing DNA double-strand breaks.
Turcotte V; Fortin S; Vevey F; Coulombe Y; Lacroix J; Côté MF; Masson JY; C-Gaudreault R
J Med Chem; 2012 Jul; 55(13):6194-208. PubMed ID: 22694057
[TBL] [Abstract][Full Text] [Related]
18. A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022).
Gehlot P; Vyas VK
Recent Pat Anticancer Drug Discov; 2024; 19(3):280-297. PubMed ID: 37070439
[TBL] [Abstract][Full Text] [Related]
19. Development of a human dihydroorotate dehydrogenase (hDHODH) pharma-similarity index approach with scaffold-hopping strategy for the design of novel potential inhibitors.
Shih KC; Lee CC; Tsai CN; Lin YS; Tang CY
PLoS One; 2014; 9(2):e87960. PubMed ID: 24504131
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold.
Li C; Zhou Y; Xu J; Zhou X; Liu S; Huang Z; Qiu Z; Zeng T; Gou K; Tao L; Zhong X; Yang X; Zhou Y; Su N; Chen Q; Zhao Y; Luo Y
Eur J Med Chem; 2022 Dec; 243():114737. PubMed ID: 36115209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
